This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Università Degli Studi Di Brescia, Universita′ Degli Studi Di Milano. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5 
1 out of 40 Years Active: 2026
Title: Andrea Casiraghi: Inventor of a Potential Parkinson’s Disease-Modifying Approach.
Introduction
Andrea Casiraghi is an inventor associated with Milan, Italy, and research at the University of Milan and the University of Brescia. His listed patent work concerns compounds investigated for their potential to modify Parkinson’s disease.
Latest Patents
Casiraghi is associated with 1 patent: “Structural Analogues of Methylphenidate as Parkinson’s Disease-Modifying Agents.” The invention describes compounds of formula (A) for potential use as Parkinson’s disease-modifying agents. According to the supplied description, these compounds can reduce alpha-synuclein aggregation and stimulate the functional interaction between alpha-synuclein and Synapsin III.
Career Highlights
Casiraghi’s listed institutional affiliations include the University of Milan and the University of Brescia. His patent work focuses on a proposed therapeutic approach involving methylphenidate analogues and biological processes relevant to Parkinson’s disease.
Collaborations
His listed collaborators include Francesca Longhena and Valentina Straniero, who is a woman. Their names are associated with the research behind the patent.
Conclusion
Andrea Casiraghi’s listed invention explores compounds that may affect alpha-synuclein aggregation and its interaction with Synapsin III, highlighting a potential direction for Parkinson’s disease research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile